Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024

BUY
$1.35 - $2.27 $19,305 - $32,461
14,300 New
14,300 $23,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $3.61 $112,320 - $225,264
62,400 Added 624.0%
72,400 $152,000
Q2 2023

Aug 11, 2023

BUY
$1.14 - $1.63 $11,399 - $16,299
10,000 New
10,000 $16,000
Q3 2022

Nov 14, 2022

SELL
$2.04 - $4.32 $9,588 - $20,304
-4,700 Reduced 27.17%
12,600 $26,000
Q2 2022

Aug 15, 2022

BUY
$3.02 - $4.56 $4,832 - $7,295
1,600 Added 10.19%
17,300 $69,000
Q4 2021

Feb 14, 2022

SELL
$6.7 - $11.38 $109,880 - $186,632
-16,400 Reduced 51.09%
15,700 $113,000
Q3 2021

Nov 15, 2021

SELL
$10.11 - $17.56 $12,132 - $21,072
-1,200 Reduced 3.6%
32,100 $345,000
Q2 2021

Aug 11, 2021

SELL
$14.9 - $20.82 $1.17 Million - $1.64 Million
-78,600 Reduced 70.24%
33,300 $576,000
Q1 2021

May 17, 2021

BUY
$12.57 - $21.22 $627,243 - $1.06 Million
49,900 Added 80.48%
111,900 $2.38 Million
Q4 2020

Feb 16, 2021

SELL
$8.73 - $14.56 $68,967 - $115,024
-7,900 Reduced 11.3%
62,000 $818,000
Q3 2020

Nov 16, 2020

BUY
$8.56 - $11.6 $167,776 - $227,360
19,600 Added 38.97%
69,900 $616,000
Q2 2020

Aug 14, 2020

BUY
$6.63 - $12.85 $204,204 - $395,780
30,800 Added 157.95%
50,300 $502,000
Q1 2020

May 15, 2020

SELL
$6.94 - $14.42 $886,932 - $1.84 Million
-127,800 Reduced 86.76%
19,500 $143,000
Q3 2019

Nov 14, 2019

BUY
$5.62 - $7.86 $124,202 - $173,706
22,100 Added 17.65%
147,300 $1.01 Million
Q2 2019

Aug 14, 2019

BUY
$4.53 - $7.0 $381,879 - $590,100
84,300 Added 206.11%
125,200 $798,000
Q1 2019

May 15, 2019

BUY
$3.65 - $6.05 $67,525 - $111,925
18,500 Added 82.59%
40,900 $211,000
Q4 2018

Feb 14, 2019

BUY
$2.54 - $4.34 $56,896 - $97,216
22,400 New
22,400 $83,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $42.6M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.